Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Remicade Biosimilars: Samsung Looks To Follow Celltrion's Footsteps

Related Content

Merck’s Revised Biosimilar Strategy Poised To Deliver

Apr 06 2015

Related Companies

Celltrion, Inc.

Samsung Bioepis Co., Ltd.

Johnson & Johnson

Samsung Bioepis Co., Ltd.

Biogen, Inc.

Merck & Co., Inc.

Pfizer Inc.

Novartis AG

Additional Topics

United States South Korea Asia Pacific Regulation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window